title: How we do it: adjunctive intravenous midazolam: diagnosis and treatment of therapy-resistant muscle tension dysphonia.
abstract: Dysphonic patients with muscle tension are common at voice clinics. The majority respond to intensive vocal therapy. A small number of cases remain resistant to intensive vocal therapy. We have used intravenous midazolam to enhance therapy-resistant dysphonic patients' self-monitoring, their self-awareness and to change fixed patterns. Six of seven patients were discharged with restoration of normal voice 1 month after treatment.
authors.affiliation: Department of Otolaryngology, Lancashire Teaching Hospitals NHS Trust, Preston, UK. drrkbhalla@doctors.org.uk
authors.forename: R K
authors.initials: RK
authors.lastname: Bhalla
authors.forename: J
authors.initials: J
authors.lastname: Wallis
authors.forename: V
authors.initials: V
authors.lastname: Kaushik
authors.forename: J P
authors.initials: JP
authors.lastname: Carpentier
mesh_terms: D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D007821:Laryngeal Muscles / Q000187:drug effects / Q000503:physiopathology*; D008874:Midazolam / Q000008:administration & dosage / Q000627:therapeutic use*; D009119:Muscle Contraction / Q000187:drug effects; D013070:Speech Therapy / Q000379:methods*; D016896:Treatment Outcome; D014832:Voice Disorders / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D014833:Voice Quality
chemical_list: D014151:Anti-Anxiety Agents; D008874:Midazolam